[decorative logo] Lymphovenous Canada: What are Lymphatic Disorders?

Overview of the lymphatic system - links
National Lymphedema Network medical position papers
Diagnostic tools
Antibiotic use in preventing infection

The lymphatic system is very important to our bodies. The success of organ transplants and the ability of burn victims to survive depends largely on how effectively their lymphatic system is working. Our lymphatic system has the pressure of thousands of tiny hearts which pump lymph fluid throughout our bodies.

The delicate, spider web like channels which make up our lymphatic system are present throughout our bodies. Their primary function is to remove foreign material - such as infectious agents - from body tissues. They also serve to bathe tissues with nutrients and fluids. In addition the lymphatic system functions along with the circulatory system to absorb nutrients from the small intestines. A large portion of digested fats are absorbed via the lymphatic capillaries. Lymphedema can develop when the channels and ducts that transport lymph fluid are missing, impaired, or damaged. As a result, lymphatic fluid accumulates in various parts of the body, causing swelling.


Lymphatic disorders can include: lymphedema, Klippel-Trenaunay (KT) syndrome, lymphangioma, hemangioma, and vascular malformations. Individuals may be born with these conditions, or develop them later in life. Lymphedema is present in about 70% of Turner Syndrome - a chromosomal disorder in which part or all of one of a woman's X chromosomes is missing. It is thought that the malfunction of the lymphatic system may be involved in such auto immune diseases such as arthritis and Crohn's disease.

Many individuals acquire lymphovenous disorders such as lymphedema as a result of the removal of lymph nodes during surgery or through damage to the nodes and lymphatic vessels following radiation used in the treatment of cancer. Other causes may include trauma to the limb or parasitic infiltration of the lymph nodes and vessels (such as lymphatic filariasis, common in tropical areas). In fact, it is estimated that as many as one quarter of world's population is affected by lymphatic filariasis.

3-5 million people are estimated to be effected by secondary lymphedema in the U.S.

There are few Canadian statistics which exist on the numbers of people with secondary lymphedema - however 3-5 million people are estimated to be affected with secondary lymphedema in the United States. In December 2000 the U.S. National Institutes of Health gave the following description and statistical breakdown of the incidence of lymphedema:

There are two major types of lymphedema: (the less common) primary (congenital)lymphedema and (most common) secondary lymphedema (caused by tissue injury, scarring, lymph node removal, or infection). The incidence of primary lymphedema has been estimated in the U.S. to be between 1/6000 to 1/300 live births. For primary lymphedema, there is an early onset form (Milroy's disease) which is relatively rare and presents at birth. A more common type (Meige's disease) develops during puberty, representing approximately 80 percent of all cases (of primary lymphedema). A third form, lymphedema tarda, occurs after the age of 35...

The largest percentage of this group are breast cancer survivors. The American Cancer Society (Understanding and Managing Lymphedema After Cancer Treatment, page 20, 2006) suggests that 1 in 5 of breast cancer survivors in the U.S. are at risk of getting lymphedema.

Obesity has been suggested as a major predictive factor for arm edema in breast cancer

Obesity has been suggested as a major predictive factor for arm edema in breast cancer. At the May 2, 2006 annual meeting of the American Society of Breast Disease (ASBD) Lucy K. Helyer, MD, surgical oncology fellow, Princess Margaret Hospital University Health Network in Canada reported on recent findings from their study which confirms earlier research in this area.

Dr. Helyer followed 137 women with breast cancer who underwent sentinel node biopsies. Close to 36% of patients who were obese developed lymphedema in contrast to about 16% of overweight patients, about 7% of normal weight patients and none in underweight patients.

Other studies have previously shown a link between obesity and lymphedema. These include: Arm edema in conservatively managed breast cancer: obesity is a major predictive factor, Therapeutic Radiology, 1991, Jul: 180(1):18; Obesity and cancer: the risks, science, and potential management strategies, Oncology 2005 Jun; 19(7): 871-81). Authors Say and Donegan (A biostatistical evaluation of complications from mastectomy. Surg. Gynecol, 1974) have suggested that individuals who are overweight often have prolonged operations and multiple transfusions, leading to arm edema, which they attributed to poorer vascularity of overweight patients. Other authors such as Haagensen (Diseases of the Breast, Philadelphia: Saunders, 1971) have suggested that infection is more difficult to avoid in patients who are obese.

In the Lymphlink Question Corner on obesity, the U.S. National Lymhedema Network notes that "it would be fair to extrapolate similar risks to leg LE (lymphedema) and excess weight too."

The 2007 publication Lymphedema available from the U.S. National Cancer Insitute (NCI) makes the following commments on lymphedema prevalence rates:

"...the reported incidence of lymphedema varies because of discrepancies in its definition and measurement and because of variations in time since treatment after which subjects are assessed for this complication. The incidence also varies according to treatment received and limb involved. With these caveats understood, there appears to be an overall incidence of arm edema after breast cancer therapy of 26%. A survey of 1,151 women treated with radiation for breast cancer reported lymphedema in 23% of subjects at 0 to 2 years posttreatment and 45% at 15 or more years posttreatment. Among breast cancer patients treated with surgery alone, prevalence increased from 20% at 0 to 2 years postsurgery to 30% at 15 or more years postsurgery. In a retrospective study, women who underwent radiation therapy following treatment for vulvar cancer with removal of lymph nodes were at higher risk (47%) for developing lower limb lymphedema (LLL) than were survivors of ovarian cancer (7%), uterine cancer (17.7%), or cervical cancer (17.5%). Of those with LLL, 70.8% had onset within 6 months of surgery.

Factors that contribute to the development of lymphedema are irradiation of the dissected nodal basin, postoperative wound complications and subsequent cellulitis of the limb, the extent of node dissection, and advanced age.

The following are risk factors for the development of lymphedema:
- Breast cancer, if patients have received radiation therapy or undergone node dissection. Radiation therapy to the axilla following axillary node dissection increases the incidence of lymphedema. A review of several studies reports lymphedema in approximately 41% (range, 21%-51%) of patients who underwent axillary radiation and surgery, compared with 17% (range, 6%-39%) of those receiving axillary surgery without radiation.[7] The extent of axillary dissection also increases the risk of lymphedema.
- Nodal dissection of axillary, inguinal, or pelvic regions.
- Radiation therapy of axillary, inguinal, or pelvic regions or supraclavicular (mantle field) radiation.
- Scarring of the left or right subclavian lymphatic ducts and veins by either surgery or radiation."

In 1997 the National Cancer Institute (NCI) in the U.S. reported that other cancer survivors at risk for lymphedema also included those who have undergone surgery and/or radiation treatment for malignant melanoma of the upper or lower extremities, prostate cancer, gynecologic cancers, ovarian, testicular/prostate cancers, colorectal, pancreatic, or liver cancers.

World wide as many as 120 million people are affected with lymphatic filariasis

World wide as many as 120 million people are affected with lymphatic filariasis according to the World Health Organization (WHO), with over 40 million people seriously incapacitated and disfigured by the disease. The extreme form of this disease is referred to as "Elephantiasis".

WHO reports that,"one-third of the people infected with the disease live in India, one third are in Africa and most of the remainder are in South Asia, the Pacific and the Americas. In tropical and subtropical areas where lymphatic filariasis is well-established, the prevalence of infection is continuing to increase. A primary cause of this increase is the rapid and unplanned growth of cities, which creates numerous breeding sites for the mosquitoes that transmit the disease...

In its most obvious manifestations, lymphatic filariasis causes enlargement of the entire leg or arm, the genitals, vulva and breasts. In endemic communities, 10-50% of men and up to 10% of women can be affected. The psychological and social stigma associated with these aspects of the disease are immense. In addition, even more common than the overt abnormalities is hidden, internal damage to the kidneys and lymphatic system caused by the filariae."

No cure currently exists, however a range of options are available to keep the swelling under control

While no cure currently exists, there are a range of options available which can keep the swelling associated with lymphedema under control, thus reducing the possibility of infection and secondary skin change. See Compression page for more information in this area. These options can also help to maintain the motion and function of the affected limbs. (Note: after these treatments are used, limbs/affected areas of the body must be wrapped either in low stretch bandages or compression garments to maintain the reduction.)

OTHER TYPES OF TREATMENT:

With all lymphatic disorders it is important to avoid the use of needles in the affected area, unless there is no other choice.

Make sure you check with your doctor or other health care specialists in developing your treatment plan.

There are a number of other disorders which may look similar to some lymphovenous disorders such as lymphedema but are not the same. These include a condition known as "lipodema" which is an abnormal accumulation of fat in the hips and legs to the ankles (see the Research & Advisories section for more information on this topic), and swelling which can result from blood clots.

An examination by your doctor and/or specialists, along with a number of diagnostic tests, can help to verify your condition. It is recommended that you determine what your condition might be before embarking on any treatment program.


Home | Events | Canadian Lymphedema Framework | Treatment Programs in Canada | Groups and Organizations
Research & Advisories | Exercise | Cancer Treatment | Compression | Massage and Physiotherapy
Dermatology and Wound Care | Tropical Lymphedema | Children's Corner
Suppliers | Library | Links to Other Sites | Support Us!

Copyright © 1996-2013 Lymphovenous Canada.
Please do not reproduce material from this site without permission.
If you have any comments, you can contact us at info@lymphovenous-canada.ca.
Last revised August 25, 2012.